Panagora Asset Management’s 10x Genomics TXG Stock Holding History

Panagora Asset Management’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-78,046	Closed	-$904K	–	1250
2025 Q2	$904K	Buy	+78,046	New	+$711K	﹤0.01%	648
2022 Q2	–	Sell	-3,166	Closed	-$241K	–	1593
2022 Q1	$241K	Hold	3,166	–	–	﹤0.01%	1412
2021 Q4	$472K	Sell	3,166 -764	-19%	-$117K	﹤0.01%	1239
2021 Q3	$572K	Hold	3,930	–	–	﹤0.01%	1253
2021 Q2	$770K	Sell	3,930 -15	-0.4%	-$2.71K	﹤0.01%	1132
2021 Q1	$714K	Buy	3,945 +1,981	+101%	+$342K	﹤0.01%	1165
2020 Q4	$278K	Buy	+1,964	New	+$285K	﹤0.01%	1453
2019 Q4	–	Sell	-1,000	Closed	-$50K	–	2576
2019 Q3	$50K	Buy	+1,000	New	+$55.3K	﹤0.01%	1958

Other funds holding TXG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

QCM

Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Panagora Asset Management's TXG Position: Q3 2025 in Review

Panagora Asset Management sold out of 10x Genomics (TXG) in Q3 2025, closing a stake of 78,046 shares — an estimated $904K sold.

Panagora Asset Management first reported a position in TXG in Q3 2019 and held it in 8 quarters. The position peaked at $904K in Q2 2025. 317 funds tracked by Wall St. Rank hold TXG as of Q3 2025.

Panagora Asset Management reported no remaining 10x Genomics position as of Q3 2025 after selling out during the quarter.
Panagora Asset Management sold 78,046 10x Genomics shares in Q3 2025, an estimated $904K.
Panagora Asset Management first reported a position in 10x Genomics in Q3 2019 and held it in 8 quarters.
Panagora Asset Management's 10x Genomics position peaked at $904K in Q2 2025.
317 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2025.

Based on Panagora Asset Management's 13F filing for Q3 2025, filed 13 Nov 2025.